Rege Nephro Co.,Ltd

Rege Nephro is a clinical-stage biotech company developing small molecule for ADPKD discovered through iPSC-derived human disease models and cell therapy for chronic kidney disease by iPSC-derived nephron progenitor cells

Address

Kyoto
Kyoto
Japan
Loading